Evidence map›Paper›PMID 36642767›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2023

Bacterial contamination of multi-use antibiotic steroid eye ointments and drops.

Omer Faruk Yilmaz, Abdurrahman Sarmis, Muhammed Ali Mutlu, Esma Ecem Ersoy, Ulviyya Askarova, Halit Oguz

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Ocular surface lesions in clinical grades of Bell's phenomenon.Medical hypothesis, discovery & innovation ophthalmology journal · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Omer Faruk YilmazDepartment of Ophthalmology, Goztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey. dryilmazof@yahoo.com.ORCID http://orcid.org/0000-0001-5571-3735
Abdurrahman SarmisDepartment of Medical Microbiology, Goztepe Prof. Dr. Süleyman Yalçin City Hospital, Istanbul, Turkey.
Muhammed Ali MutluDepartment of Medical Microbiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
Esma Ecem ErsoyDepartment of Ophthalmology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Ulviyya AskarovaDepartment of Ophthalmology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Halit OguzDepartment of Ophthalmology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Istanbul Medeniyet University · TRFatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi · TRIstanbul Eye Hospital · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis comprehensive prospective study aimed to investigate the bacterial contamination of antibiotic steroid eye ointments and drops frequently used by eye patients.

methodIn this comprehensive prospective study, a total of 410 multi-use topical eye medications containing 15 different ingredients from 22 pharmaceutical companies used by 185 patients were analyzed. Four groups were formed as follows: group 1: antibiotic ointments (n: 109); group 2: antibiotic drops (n: 103); group 3: steroid ointments (n: 67); and group 4: steroid drops (n: 131). Topical multi-use eye drops and ointments used by patients at home for at least 1 week were randomly collected. The caps and contents were separately bacteriologically examined in a chocolate agar medium.

resultsOur study detected bacterial contamination in 23 containers (5.6%) of the total 410 topical drugs. According to the groups, bacterial contamination was detected in 10 of 67 (14.9%) steroid ointments, 6 of 109 (5.5%) antibiotic ointments, 4 of 131(3.1%) steroid drops, and 3 of 103 (2.9%) antibiotic drops. While the bacterial contamination rate in ointments was 9.1%, this rate was 3% in drops. The difference between them was statistically significant (p = 0.015). According to the post-hoc pairwise comparisons, the difference between steroid drops and steroid ointment (p = 0.0023) was statistically significant. Among all drugs, contamination was detected in 12 of the 93 (12.9%) containers used after keratitis, conjunctivitis, and inflammatory conditions. It was determined that preservatives statistically reduced bacterial growth on the cap. The preservatives did not have a statistically significant effect on the bacterial contamination of the contents compared to the caps. While all contaminations were detected in illiterate and primary school graduates, no contamination was seen in the drugs used by any secondary school or university graduate.

conclusionOur study detected contamination in all topical ophthalmic drug groups. Contamination rates were found to be higher in ointments and steroids. Bacterial contamination was also seen in drugs containing preservatives. We should be careful in the use of topical medications. We do not recommend the bilateral use of ointments and drops in infected eyes, such as those with keratitis, or after intraocular surgeries, such as those for cataracts.

Indexed as

Anti-Bacterial AgentsKeratitisBacteriaHumansOintmentsOphthalmic SolutionsProspective StudiesSteroidsAnti-Bacterial AgentsOintmentsOphthalmic SolutionsSteroidsBacterial contaminationMulti-use antibiotic dropsMulti-use antibiotic ointmentsMulti-use steroid dropsMulti-use steroid ointments

Identifiers

PMID36642767
OpenAlexW4316345204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.